Clinical effectiveness and safety of once-weekly glp-1 receptor agonist dulaglutide as add-on to metformin or metformin plus insulin secretagogues in obesity and type 2 diabetes
ISSN
20770383
Date Issued
2021
Author(s)
DOI
10.3390/jcm10050985
Subjects